Cargando…

Prognostic Value of Cardiac Troponin T and Sex in Patients Undergoing Elective Percutaneous Coronary Intervention

BACKGROUND: In patients with stable coronary artery disease undergoing elective percutaneous coronary intervention, the prognostic value of high‐sensitivity cardiac troponin T (hs‐cTnT) and the influence of sex remain poorly defined. METHODS AND RESULTS: Consecutive patients with stable coronary art...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harada, Yukinori, Michel, Jonathan, Koenig, Wolfgang, Rheude, Tobias, Colleran, Roisin, Giacoppo, Daniele, Kastrati, Adnan, Byrne, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210430/ https://www.ncbi.nlm.nih.gov/pubmed/27895042 http://dx.doi.org/10.1161/JAHA.116.004464

Ejemplares similares

Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial
por: Harada, Yukinori, et al.
Publicado: (2016)

Association of interleukin 6 -174 G/C polymorphism with coronary artery disease and circulating IL-6 levels: a systematic review and meta-analysis
por: Rai, Himanshu, et al.
Publicado: (2021)

Troponin I elevation after elective percutaneous coronary interventions: Prevalence and risk factors
por: Ferreira, Roberto Muniz, et al.
Publicado: (2017)

Target and non-target vessel related events at 10 years post percutaneous coronary intervention
por: Coughlan, J. J., et al.
Publicado: (2022)

Myocardial infarction after elective percutaneous coronary intervention—which cardiac troponin cut-off to use?
por: Eggers, Kai M, et al.
Publicado: (2021)

Prognostic significance of Troponin I in patients undergoing primary percutaneous coronary intervention
por: Sane, Pratik Sudhir, et al.
Publicado: (2021)

Coronary No-Reflow after Primary Percutaneous Coronary Intervention—Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy
por: Ndrepepa, Gjin, et al.
Publicado: (2023)

Midregional-proAtrial Natriuretic Peptide and High Sensitive Troponin T Strongly Predict Adverse Outcome in Patients Undergoing Percutaneous Repair of Mitral Valve Regurgitation
por: Wöhrle, Jochen, et al.
Publicado: (2015)

Left Ventricular Twist and Untwist in Patients Undergoing Elective Percutaneous Coronary Intervention
por: Elzieny, Ali A., et al.
Publicado: (2021)

Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention
por: Pang, Zhihua, et al.
Publicado: (2017)

Effects of Baseline Thrombocytopenia on In-hospital Outcomes in Patients Undergoing Elective Percutaneous Coronary Intervention
por: Shiraishi, Jun, et al.
Publicado: (2019)

Prognostic value of mean platelet volume in patients undergoing elective percutaneous coronary intervention
por: Seyyed-Mohammadzad, Mir Hossein, et al.
Publicado: (2015)

Periprocedural myocardial and renal injury in patients undergoing elective percutaneous coronary interventions – is there an association?
por: Stipinovic, Mario, et al.
Publicado: (2019)

High-Sensitivity Cardiac Troponin T in Patients with Severe Chronic Kidney Disease and Suspected Acute Coronary Syndrome
por: Alushi, Brunilda, et al.
Publicado: (2021)

One year VARC-2-defined clinical outcomes after transcatheter aortic valve implantation with the SAPIEN 3
por: Pellegrini, Costanza, et al.
Publicado: (2019)

Rise of serum troponin levels following uncomplicated elective percutaneous coronary interventions in patients without clinical and procedural signs suggestive of myocardial necrosis
por: Buturak, Ali, et al.
Publicado: (2016)

The Impact of Prediabetes on Two-Year Clinical Outcomes in Patients Undergoing Elective Percutaneous Coronary Intervention
por: Choi, Woong gil, et al.
Publicado: (2018)

One‐year clinical outcome with a novel self‐expanding transcatheter heart valve
por: Pellegrini, Costanza, et al.
Publicado: (2019)

Meta-Analysis of Short vs. Prolonged Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation and Role of Continuation with either Aspirin or a P2Y(12) Inhibitor Thereafter
por: Lahu, Shqipdona, et al.
Publicado: (2022)

The Prognostic Value of Cardiac Troponin I in Patients with or without Three-Vessel Disease Undergoing Complete Percutaneous Coronary Intervention
por: Li, Zhi-Fan, et al.
Publicado: (2022)

Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study)
por: Giacoppo, Daniele, et al.
Publicado: (2019)

The effect of dalteparin versus unfractionated heparin on the levels of troponin I and creatine kinase isoenzyme MB in elective percutaneous coronary intervention: a multicenter study
por: Zhang, Guangming, et al.
Publicado: (2014)

Cardiac Troponin I in Patients Undergoing Percutaneous and Surgical Myocardial Revascularization: Comparison of Analytical Methods
por: Vendramini, Sabrina Pacheco do Amaral, et al.
Publicado: (2023)

Comparison of latest generation supra-annular and intra-annular self-expanding transcatheter heart valves
por: Pellegrini, Costanza, et al.
Publicado: (2020)

Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention
por: Zhou, You, et al.
Publicado: (2021)

Comparison of long-term outcome in patients with calcified stenosis treated with intravascular lithotripsy or with modified balloon angioplasty: a propensity score-adjusted study
por: Leick, Jürgen, et al.
Publicado: (2023)

High-dose atorvastatin pretreatment could diminishes microvascular impairment in patients undergoing elective percutaneous coronary intervention
por: He, Gui-Xin, et al.
Publicado: (2013)

Differences Among Body Mass Index (BMI) Groups in Patients Undergoing First Elective Percutaneous Coronary Intervention
por: Simoni, Leonard, et al.
Publicado: (2015)

Novel Patient‐Centered Approach to Facilitate Same‐Day Discharge in Patients Undergoing Elective Percutaneous Coronary Intervention
por: Amin, Amit P., et al.
Publicado: (2018)

Increased urinary adiponectin level is associated with contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention
por: Zhang, Jun-yi, et al.
Publicado: (2019)

Comparison of Patient-Reported vs Physician-Estimated Angina in Patients Undergoing Elective and Urgent Percutaneous Coronary Intervention
por: Saxon, John T., et al.
Publicado: (2020)

Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention
por: Habibi, Zarina, et al.
Publicado: (2023)

Predicting Postoperative Troponin in Patients Undergoing Elective Hip or Knee Arthroplasty: A Comparison of Five Cardiac Risk Prediction Tools
por: Tesfazghi, Merih T., et al.
Publicado: (2022)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
por: ten Berg, Jurriën M, et al.
Publicado: (2001)

Multimarker risk stratification approach and cardiovascular outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention
por: Mehta, Vimal, et al.
Publicado: (2016)

Relationship Between Troponin on Presentation and In‐Hospital Mortality in Patients With ST‐Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Wanamaker, Brett L., et al.
Publicado: (2019)

Effects of high dose atorvastatin before elective percutaneous coronary intervention on highly sensitive troponin T and one year major cardiovascular events; a randomized clinical trial()
por: Pourhosseini, HamidReza, et al.
Publicado: (2019)

Efficacy and safety of nicorandil on perioperative myocardial injury in patients undergoing elective percutaneous coronary intervention: results of the PENMIPCI trial
por: Ye, Ziliang, et al.
Publicado: (2018)

Association between serum angiopoietin-2 concentrations and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention
por: Jian, Wen, et al.
Publicado: (2020)

Impact of Diabetes Mellitus on One-Year Clinical Outcomes in Patients Anticoagulated with Bivalirudin Undergoing Elective Percutaneous Coronary Intervention
por: Li, Yulong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_beerirlk78sjevbfgiarp53q8o